Virtua Health, Inc.   Report issue

Academic/Hospital Phase 4
Founded: Marlton NJ United States (1998)

Organization Overview

First Clinical Trial
2016
NCT03514277
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Adam Thaler | Princpal Investigator | Virtua Health, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 4)

Intervertebral Disc Degeneration (Phase 4)

Low Back Pain (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Radiculopathy (Phase 4)

Spondylolisthesis (Phase 4)

Spondylolysis (Phase 4)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4